Highlights ODI Pharma AB

Equities

ODI

SE0013409760

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
7.7 ^SEK	-1.91%		+6.21%	+54.00%

02/05	ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	CI
22/02	ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	02/05	CI
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	22/02	CI
ODI Pharma Sells CBD Skincare Brand for SEK3 Million	06/12	MT
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2023	24/11	CI
ODI Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	24/23/24	CI
ODI Pharma’s Stock Soars After Exclusive Supplier Deal With Synoptis Pharma	07/23/07	MT
ODI Phaa AB Enters into Exclusive Collaboration with Synoptis Pharma Sp. Z o.o	07/23/07	CI
ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	25/23/25	CI
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23/23/23	CI
ODI Pharma Receives Approval from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland to Distribute and Sell Its Products on the Polish Market	24/23/24	CI
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2022	26/22/26	CI
ODI Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2022	25/22/25	CI
ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	25/22/25	CI
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	24/22/24	CI
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2021	25/21/25	CI
Odi Pharma AB to Launch Kandol, the CBD Skincare Product Line	28/21/28	CI
ODI Pharma AB Reports Earning Results for the Fourth Quarter and Full Year Ended June 30, 2021	26/21/26	CI
ODI Pharma AB Approves the Official Launch of Kandol	17/21/17	CI
ODI Pharma AB Announces Group Earnings Results for the Third Quarter and Nine Months Ended March 31, 2021	27/21/27	CI
ODI Pharma Provides Update on progress in "Project Poland" and "Project Skin"	21/21/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ODI Pharma AB

Equities

ODI

SE0013409760

Highlights

Filters